Share on StockTwits
 

Investment Analysts’ upgrades for Wednesday, January 8th:

Apollo Group (NASDAQ:APOL) was upgraded by analysts at Compass Point from a sell rating to a neutral rating. Compass Point currently has $30.00 price target on the stock, up from their previous price target of $20.00.

Athlon Energy (NASDAQ:ATHL) was upgraded by analysts at Howard Weil from a sector perform rating to an outperform rating. They currently have $38.00 price target on the stock.

Bill Barrett Corp. (NYSE:BBG) was upgraded by analysts at Howard Weil from a sector perform rating to an outperform rating. The firm currently has $34.00 price target on the stock.

BP PLC (NYSE:BP) was upgraded by analysts at Howard Weil from a sector perform rating to an outperform rating. The firm currently has $56.00 target price on the stock, up from their previous target price of $51.00.

Concho Resources (NYSE:CXO) was upgraded by analysts at Howard Weil from an outperform rating to a focus stock rating.

FLIR Systems (NASDAQ:FLIR) was upgraded by analysts at Drexel Hamilton from a hold rating to a buy rating.

Goodrich Petroleum Corp. (NYSE:GDP) was upgraded by analysts at Howard Weil from an outperform rating to a focus list rating.

Jamba (NASDAQ:JMBA) was upgraded by analysts at Dougherty & Co from a neutral rating to a buy rating.

Lake Shore Gold Corp Ordinary (NYSE:LSG) was upgraded by analysts at CIBC from an underperform rating to a sector perform rating.

Manitowoc (NYSE:MTW) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. The firm currently has $30.00 price target on the stock, up from their previous price target of $23.00. The analysts wrote, “When we launched coverage of MTW in Sept, the sole reason behind our EW recommendation was our skepticism around the timing of a Non-Resi recovery,” the report said. “However, over the past two months, we have become increasingly bullish on the end market outlook, on the back of improving leading indicators (Dodge, ABI) and growing Resi active community count (now happening for the first time this cycle). As such, we project 5% US Non-Resi investment growth, which should translate to 10%+ growth in Crane sales by 2015e.” Some highlights from the report include: -”ConExpo has been a positive catalyst for order activity in past years, resulting in 34% and 16% Q/Q order growth in 2005 and 2008, respectively. We expect a similar result in 1Q14.”-”Valuation does not look stretched; MTW trades at 16.4x NTM P/E, a mere 6% premium to peers vs. a 25% average premium during the last recovery.”

Noble Energy (NYSE:NBL) was upgraded by analysts at Howard Weil from an outperform rating to a focus stock rating. The firm currently has $85.00 target price on the stock.

PBF Energy (NYSE:PBF) was upgraded by analysts at Howard Weil from a sector perform rating to an outperform rating. They currently have $36.00 target price on the stock.

Pace plc (LON:PIC) was upgraded by analysts at BNP Paribas to an outperform rating. They currently have GBX 400 ($6.56) target price on the stock.

Persimmon (LON:PSN) was upgraded by analysts at Numis Securities Ltd to a hold rating. The firm currently has GBX 1,300 ($21.32) price target on the stock.

Phillips 66 (NYSE:PSX) was upgraded by analysts at Howard Weil from a sector perform rating to an outperform rating. Howard Weil currently has $85.00 target price on the stock.

SAP Aktiengesellschaft (NYSE:SAP) was upgraded by analysts at UBS AG from a neutral rating to a buy rating.

Targa Resources Corp. (NASDAQ:TRGP) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating.

Union Pacific Corp. (NYSE:UNP) was upgraded by analysts at Sanford C. Bernstein from a market perform rating to an outperform rating.

Valeant Pharmaceuticals (NYSE:VRX) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. They currently have $145.00 price target on the stock. The analysts wrote, “We believe VRX will be able to continue to raise U.S. list prices aggressively in coming years because its drugs are primarily in niche categories (derm, eye care, podiatry) that payers do not aggressively manage,” the report said. “In addition, the business mix has shifted to more durable assets. VRX now generates the majority of rev from EM branded generics, aesthetics, consumer, and devices (see Exhibit 2 on p. 3). Only 10% of pro forma 2013E rev is subject to patent cliffs and no more than 3% of rev is at risk to generics annually in ’14-’17E according to mgmt. We now foresee greater top-line durability, and we raised terminal growth from -2% to 0%.” Some highlights from the report included: -”We view Valeant as one of the best positioned specialty pharmaceutical companies to capitalize on industry consolidation.”-”Easier organic growth comps in 2H:14 and prospects for future M&A should drive more positive investor perception.”-”We are now more positive on terminal growth prospects given the diversity of Valeant’s business and limited patent cliff risk.”

Whiting Petroleum Corp. (NYSE:WLL) was upgraded by analysts at Howard Weil from an outperform rating to a focus stock rating. The firm currently has $95.00 target price on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.